Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
D001943:Breast Neoplasms / Q000188:drug therapy; D003248:Constipation / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008223:Lymphoma / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D012075:Remission, Spontaneous; D013921:Thrombocytopenia / Q000139:chemically induced; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity
D014750:Vincristine